Aspirin sensitizes osimertinib‐resistant NSCLC cells <i>in vitro</i> and <i>in vivo</i> via Bim‐dependent apoptosis inductionRui Han|Molecular Oncology|2020Cited by 31
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancerRui Han, Yong He|Acta Pharmacologica Sinica|2024Cited by 20